Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Arthritis Research & Therapy|April 10, 2013
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodiesMaria J LeandroArthritis Research & Therapy|October 13, 2009
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritisMaria J LeandroInfectious Disease Clinics of North America|April 27, 2020
Infections Related to Biologics: Agents Targeting B CellsMaria J LeandroBest Practice & Research. Clinical Rheumatology|December 6, 2011
B-cell therapies in established rheumatoid arthritisMaria J Leandro, Elena Becerra-FernandezRheumatology (Oxford, England)|May 16, 2019
The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatmentAna C Duarte, Joanna C Porter, Maria J LeandroCurrent Directions in Autoimmunity|November 27, 2004
B lymphocyte depletion in rheumatoid arthritis: targeting of CD20Jonathan C W Edwards, Maria J Leandro, Geraldine CambridgeArthritis Care & Research|July 19, 2016
Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum ImmunoglobulinsVenkat Reddy, Lina Martinez, David A Isenberg, et al.Arthritis and Rheumatism|February 1, 2006
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritisMaria J Leandro, Geraldine Cambridge, Michael R Ehrenstein, et al.Clinical and Experimental Rheumatology|April 19, 2012
Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximabInmaculada de la Torre, Maria J Leandro, Jonathan C W Edwards, et al.Arthritis and Rheumatism|October 18, 2002
An open study of B lymphocyte depletion in systemic lupus erythematosusMaria J Leandro, Jonathan C Edwards, Geraldine Cambridge, et al.Pageof 3